Search
Now showing items 11-12 of 12
Suppressing prostate cancer by targeting NGAL
(International Journal of Molecular Medicine, 2014)
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer
(International Journal of Molecular Medicine, 2014)